TMJ Stock Chart & Stats
€150.50
-€10.60(-6.63%)
At close: 4:00 PM EDT
€150.50
-€10.60(-6.63%)
Day’s Range― - ―
52-Week Range€112.00 - €165.30
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€11.35B
Enterprise Value€17.04B
Total Cash (Recent Filing)€455.38M
Total Debt (Recent Filing)€2.94B
Price to Earnings (P/E)10.9
Beta0.15
Next Earnings
Oct 28, 2026EPS Estimate
4.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)15.22
Shares Outstanding76,849,450
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)1.89
Price to Sales (P/S)1.89
P/FCF Ratio9.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€171.94Price Target Upside14.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)13.49
Revenue Forecast (FY)€5.49B
Bulls Say, Bears Say
Bulls Say
Sustained Premium GrowthRecurring premium growth supports durable revenue visibility for an insurer, while especially strong health expansion broadens the earnings base. Management’s guidance indicates the momentum is expected to persist beyond one quarter, supported by continued demand for protection-oriented coverage.
Strong Cash GenerationConsistently high conversion of earnings into free cash flow indicates that reported profits are supported by cash generation. This gives Globe Life flexibility to fund claims, invest in operations, maintain dividends, and repurchase shares without relying exclusively on external capital.
Conservative Investment And Capital PositionA high-quality investment portfolio and strong risk-based capital position strengthen the company’s ability to withstand insurance volatility and preserve policyholder security. These characteristics also support dependable investment income and provide capacity for sustained capital returns.
Bears Say
Health Claims And Margin VolatilityHigher health obligations and a lower underwriting margin show that claims experience is pressuring profitability in a meaningful business line. If elevated claims or adverse adjustments persist, they could reduce earnings quality and make future health margins less predictable.
Distribution Pressure At DTC And AILWeakness in digital acquisition and the AIL agent base creates a structural distribution challenge because both channels contribute to future policy production. Management expects improvement, but rebuilding search effectiveness, recruiting, and retention may require time and additional spending.
EVRI Startup LossesEVRI is currently diluting United American’s health profitability before reaching scale, creating execution risk within an expanding segment. Continued losses would weigh on consolidated margins and could require additional investment before the product contributes positively to earnings.
Globe Life News
TMJ FAQ
What was Globe Life’s price range in the past 12 months?
Globe Life lowest stock price was €112.00 and its highest was €165.30 in the past 12 months.
What is Globe Life’s market cap?
Globe Life’s market cap is €11.35B.
When is Globe Life’s upcoming earnings report date?
Globe Life’s upcoming earnings report date is Oct 28, 2026 which is in 22 days.
How were Globe Life’s earnings last quarter?
Globe Life released its earnings results on Jul 22, 2026. The company reported €3.218 earnings per share for the quarter, missing the consensus estimate of €3.274 by -€0.056.
Is Globe Life overvalued?
According to Wall Street analysts Globe Life’s price is currently Undervalued.
Does Globe Life pay dividends?
Globe Life does not currently pay dividends.
What is Globe Life’s EPS estimate?
Globe Life’s EPS estimate is 4.38.
How many shares outstanding does Globe Life have?
Globe Life has 76,849,450 shares outstanding.
What happened to Globe Life’s price movement after its last earnings report?
Globe Life reported an EPS of €3.218 in its last earnings report, missing expectations of €3.274. Following the earnings report the stock price went down -0.373%.
Which hedge fund is a major shareholder of Globe Life?
Currently, no hedge funds are holding shares in DE:TMJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Globe Life Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€171.94 (14.25% Upside)
€171.94 (14.25% Upside)
Blogger Sentiment
Neutral
DE:TMJ Sentiment 80%
Sector Average 63%
Sector Average 63%
Insider Transactions
Sold Shares
Worth €26.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.78%
12-Months-Change
Fundamentals
Return on Equity
0.76%
Trailing 12-Months
Asset Growth
5.88%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Globe Life
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
TMJ Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong positives — double-digit GAAP and operating EPS growth, premium growth (especially in health and United American), improving investment yields and conservative portfolio positioning, an expanded share repurchase program, and upward guidance aided by expected assumption-update benefits. Counterbalancing these are execution and margin pressures: DTC sales disruption from AI-driven changes in search, a YoY decline in AIL agent count (though with sequential improvement), elevated health claims and higher health obligation ratios in Q2, and a near-term drag from the EVRI startup. Investment unrealized losses are interest-rate driven and manageable per management. On balance the company emphasized resilient operations, conservative investments, returning capital to shareholders, and clear plans to address distribution and AI-related digital changes.View all DE:TMJ earnings summariesTMJ Revenue Breakdown
56.44% Life
24.31% Health
0.00% Annuity
19.65% Investment
<0.01% Corporate & Other
-0.42% Realized gains (losses)
TMJ Stock 12 Month Forecast
Average Price Target
€171.94
▲(14.25% Upside)